Gene therapy success depends on ability to advance viral delivery vectors to commercialization

May 18, 2011 in Genetics

Gene therapy success depends on ability to advance viral delivery vectors to commercialization

Enlarge

Human Gene Therapy, the official journal of nine international gene therapy societies, is an authoritative peer-reviewed journal published monthly in print and online that presents reports on the transfer and expression of genes in mammals, including humans. Credit: ©2011, Mary Ann Liebert Inc., publishers

Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues. One technology platform that is well suited for in vivo delivery of genes is based on adeno-associated viruses (AAV). As these novel therapies move closer to commercialization, so do the methods for large-scale production and efficient delivery of AAV vectors, which are documented in a series of articles published online ahead of print in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

A collection of papers explores the progress and challenges in refining the production and use of AAV-based vectors. Allay et al. describe a large-scale, commercially relevant method for producing and purifying an AAV vector for use in a clinical study in "Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated for a Hemophilia B Clinical Trial." In "Mycophenolate Mofetil Impairs Transduction of Single-Stranded Adeno-Associated Viral Vectors," Montenegro-Miranda et al. show that an used in conjunction with gene therapy to treat an inherited liver disorder impaired the activity of certain types of AAV vectors but not others. Yuan and coworkers present an improved and simplified method for generating producer cell lines that yield large amounts of AAV and exhibit stable growth, in "A Versatile Adeno-Associated Virus Vector Producer Cell Line Method for Scalable Vector Production of Different Serotypes."

Lu et al. developed a strategy for minimizing the unwanted production of AAV capsid protein by contaminating replication-competent virus that can provoke an immune response, as reported in "Systemic Elimination of de novo Synthesis from Replication-Competent AAV Contamination in the Liver." In "A Simple Method to Increase the Transduction Efficiency of Single-Stranded Adeno-Associated Virus Vectors In Vitro and In Vivo," Ma and colleagues have further optimized their method for delivering a mixed population of AAV2 vectors to enable high-efficiency transfer of large genes.

Finally, a provocative commentary by J. Fraser Wright, "New Adeno-Associated Virus Strategies to Support Momentum in the Clinic," explores how the design, manufacture, and characterization of gene therapy products have evolved based on the experience gained and lessons learned from first-generation clinical studies.

"Clinical proof of concept of AAV gene therapy has been realized in several diseases. The focus is now on issues related to commercialization including methods for large scale and high quality production of vectors," says James M. Wilson, MD, PhD, Editor-in-Chief, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia.

More information: The articles are available free online at www.liebertpub.com/hum

Provided by Mary Ann Liebert, Inc.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors

University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...

Genetics created 17 seconds ago | popularity not rated yet | comments 0 | with audio podcast

Researchers identify new circadian clock component

Northwestern University scientists have shown a gene involved in neurodegenerative disease also plays a critical role in the proper function of the circadian clock.

Genetics created May 16, 2013 | popularity 3 / 5 (1) | comments 1 | with audio podcast

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Genetics created May 16, 2013 | popularity 5 / 5 (1) | comments 3 | with audio podcast

Ethicists provide framework supporting new recommendations on reporting incidental findings in gene sequencing

In a paper published in Science Express, a group of experts led by bioethicists in the Center for Medical Ethics and Health Policy at Baylor College of Medicine provide a framework for the new American College of Medical Geneti ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0

Experts urge caution over use of new genetic sequencing techniques

The use of genome-wide analysis (GWA), where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. ...

Genetics created May 16, 2013 | popularity not rated yet | comments 0


Practice makes perfect? Not so much

Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...

The compound in the Mediterranean diet that makes cancer cells 'mortal'

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...

Study suggests new source of kidneys for transplant

Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...

Study shows how bilinguals switch between languages

(Medical Xpress)—Individuals who learn two languages at an early age seem to switch back and forth between separate "sound systems" for each language, according to new research conducted at the University of Arizona.

Do salamanders hold the solution to regeneration?

Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...

Scientists identify molecular trigger for Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...